316 related articles for article (PubMed ID: 29600322)
1. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis.
Chen CH; Tzeng CR; Wang PH; Liu WM; Chang HY; Chen HH; Chen CH
Arch Gynecol Obstet; 2018 Jul; 298(1):17-26. PubMed ID: 29600322
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
6. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
Ding N; Liu X; Jian Q; Liang Z; Wang F
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
[TBL] [Abstract][Full Text] [Related]
7. Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study.
Maged AM; Ragab MA; Shohayeb A; Saber W; Ekladious S; Hussein EA; El-Mazny A; Hany A
Int J Gynaecol Obstet; 2021 Mar; 152(3):395-400. PubMed ID: 33011968
[TBL] [Abstract][Full Text] [Related]
8. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
[TBL] [Abstract][Full Text] [Related]
9. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
Fabris AM; Cruz M; Legidos V; Iglesias C; Muñoz M; García-Velasco JA
Reprod Sci; 2017 Aug; 24(8):1221-1225. PubMed ID: 28715965
[TBL] [Abstract][Full Text] [Related]
10. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
Griesinger G; Diedrich K; Devroey P; Kolibianakis EM
Hum Reprod Update; 2006; 12(2):159-68. PubMed ID: 16254001
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders.
Zhou X; Guo P; Chen X; Ye D; Liu Y; Chen S
Int J Gynaecol Obstet; 2018 Jun; 141(3):327-331. PubMed ID: 29388691
[TBL] [Abstract][Full Text] [Related]
12. Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF/ICSI: A systematic review and meta-analysis of randomized trials.
He FF; Hu W; Yong L; Li YM
Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():65-73. PubMed ID: 37639817
[TBL] [Abstract][Full Text] [Related]
13. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
14. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials.
Hsia LH; Lee TH; Lin YH; Huang YY; Chang HJ; Liu YL
J Assist Reprod Genet; 2023 Sep; 40(9):2063-2077. PubMed ID: 37466846
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.
Zilberberg E; Haas J; Dar S; Kedem A; Machtinger R; Orvieto R
Gynecol Endocrinol; 2015 Feb; 31(2):145-7. PubMed ID: 25385007
[TBL] [Abstract][Full Text] [Related]
17. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
18. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves
Mutlu I; Demirdag E; Cevher F; Erdem A; Erdem M
J Obstet Gynaecol; 2022 Jul; 42(5):1239-1244. PubMed ID: 34565274
[TBL] [Abstract][Full Text] [Related]
19. Does 'Dual Trigger' Increase Oocyte Maturation Rate?
Ben-Haroush A; Sapir O; Salman L; Altman E; Garor R; Margalit T; Shufaro Y; Oron G
J Obstet Gynaecol; 2020 Aug; 40(6):860-862. PubMed ID: 31790320
[TBL] [Abstract][Full Text] [Related]
20. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of
Zhang C; Wu F; Wu Z; Sun B; Chen C; Qian W
Front Endocrinol (Lausanne); 2021; 12():739773. PubMed ID: 34707571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
